Microbot Medical Inc.
Microbot Medical Inc. (Nasdaq: MBOT) is a medical-device company that develops robotic technologies for minimally invasive endoluminal surgery. Its primary product is the LIBERTY® Endovascular Robotic Surgical System, a compact, single-use robotic system designed to remotely maneuver guidewires, catheters and related… From the company’s description.
In fiscal 2025, Microbot Medical Inc. reported a net loss of $13.14M. Operations used $13.05M in cash.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Microbot Medical Inc. does
In the company’s own words
Microbot Medical Inc. (Nasdaq: MBOT) is a medical-device company that develops robotic technologies for minimally invasive endoluminal surgery. Its primary product is the LIBERTY® Endovascular Robotic Surgical System, a compact, single-use robotic system designed to remotely maneuver guidewires, catheters and related devices through the body’s blood vessels during endovascular procedures. The system is FDA-cleared and is intended to serve healthcare providers, including hospitals and interventional radiology facilities, with an initial focus on peripheral vascular procedures. Microbot also owns the NovaCross® technology for intraluminal revascularization devices, acquired from Nitiloop in 2022. The company operates as a single medical-device business and relies on third parties to manufacture its products. It established U.S. sales, marketing and distribution capabilities in 2025 and began a limited U.S. market release of LIBERTY that year. Research and development expenses, net, were approximately $6.3 million in fiscal 2025.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- HINGHAM, MA
- Fiscal year end
- December
- CIK
- 883975
- SIC
- 3841
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Microbot Medical Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Microbot Medical Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Microbot Medical Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Microbot Medical Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Microbot Medical Inc.'s last four quarterly filings that the numbers alone won't show?”